News

Evidence that surveillance by mammogram in breast cancer survivors has been lacking until now

Iniparib remains an intriguing therapeutic possibility despite failing to meet its phase III primary endpoints

For the first time in at least 3 decades, the rate of women dying from lung cancer in the United States is declining

The federal agency that determines Medicare reimbursements this week proposed to fully cover the cost of Provenge

An FDA panel voted 7 to 3 (2 abstentions) in support of the NovoTTF-100A System

Bristol-Myers Squibb plans to start rolling out its newly approved melanoma drug ipilimumab (Yervoy) in the next several weeks

Tamoxifen, a common drug used to treat breast cancer, works by blocking the effect of estrogen on tumor cells.

Genome sequencing may help researchers understand the pathogenesis of this cancer, which despite exhaustive research, is only partially understood

The FDA has approved the novel drug ipilimumab for the treatment of patients with metastatic melanoma

Cancer researchers and patient advocates are hailing the FDA's approval of Yervoy (ipilimumab)

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop lung cancer

Nuclear crisis in Japan fuels public fears over radiation exposure

A recent clinical study reviewed the surprising results of a new prostate cancer test.

As the Avastin (bevacizumab) drama continues at the FDA, the National Comprehensive Cancer Network (NCCN) has weighed in.

Everyone can benefit from good oral hygiene, but people with cancer need to pay particular attention to their dental health

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response